These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34139463)

  • 1. Non-ambulatory measures of lower extremity sensorimotor function are associated with walking function in Multiple Sclerosis.
    Sato S; Buonaccorsi J; Miehm JD; Lim J; Rajala C; Khalighinejad F; Ionete C; Kent JA; van Emmerik REA
    Mult Scler Relat Disord; 2021 Aug; 53():103051. PubMed ID: 34139463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid foot-tapping but not hand-tapping ability is different between relapsing-remitting and progressive multiple sclerosis.
    Sato S; Lim J; Miehm JD; Buonaccorsi J; Rajala C; Khalighinejad F; Ionete C; Kent JA; van Emmerik REA
    Mult Scler Relat Disord; 2020 Jun; 41():102031. PubMed ID: 32172213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensorimotor function in progressive multiple sclerosis.
    Miehm JD; Buonaccorsi J; Lim J; Sato S; Rajala C; Averill J; Khalighinejad F; Ionete C; Jones SL; Kent JA; van Emmerik RE
    Mult Scler J Exp Transl Clin; 2020; 6(3):2055217320934835. PubMed ID: 32944271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.
    Phan-Ba R; Pace A; Calay P; Grodent P; Douchamps F; Hyde R; Hotermans C; Delvaux V; Hansen I; Moonen G; Belachew S
    Neurorehabil Neural Repair; 2011 Sep; 25(7):672-9. PubMed ID: 21436388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
    Fritz NE; Jiang A; Keller J; Zackowski KM
    Arch Phys Med Rehabil; 2016 Apr; 97(4):507-512. PubMed ID: 26577146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of walking function in multiple sclerosis supported by gait pattern analysis.
    Zörner B; Hostettler P; Meyer C; Killeen T; Gut P; Linnebank M; Weller M; Straumann D; Filli L
    Mult Scler Relat Disord; 2022 Jul; 63():103802. PubMed ID: 35487034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responder rates to fampridine differ between clinical subgroups of MS patients and patient reported outcome influences treatment decision making.
    van Munster CEP; Kaya L; Lam KH; Kalkers NF; Killestein J; Uitdehaag BMJ
    Mult Scler Relat Disord; 2020 Feb; 38():101489. PubMed ID: 31731213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative measures detect sensory and motor impairments in multiple sclerosis.
    Newsome SD; Wang JI; Kang JY; Calabresi PA; Zackowski KM
    J Neurol Sci; 2011 Jun; 305(1-2):103-11. PubMed ID: 21458828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired foot vibration sensitivity is related to altered plantar pressures during walking in people with multiple sclerosis.
    Jones SL; van Emmerik REA
    Mult Scler Relat Disord; 2023 Jul; 75():104767. PubMed ID: 37216882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.
    Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN
    Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does disability level impact the relationship of muscle strength to walking performance in people with multiple sclerosis? a cross-sectional analysis.
    Mañago MM; Callesen J; Dalgas U; Kittelson J; Schenkman M
    Mult Scler Relat Disord; 2020 Jul; 42():102052. PubMed ID: 32240963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
    Costa SL; DeLuca J; Sandroff BM; Goverover Y; Chiaravalloti ND
    J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of the 30-Second Sit-to-Stand test as a measure of lower extremity function in persons with multiple sclerosis: Preliminary evidence.
    Zheng P; Huynh TLT; Jones CD; Feasel CD; Jeng B; Motl RW
    Mult Scler Relat Disord; 2023 Mar; 71():104552. PubMed ID: 36774829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.
    Voloshyna N; Havrdová E; Hutchinson M; Nehrych T; You X; Belachew S; Hotermans C; Paes D
    Eur J Neurol; 2015 Mar; 22(3):570-7. PubMed ID: 25511792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal assessment of hand function in individuals with multiple sclerosis.
    Newsome SD; von Geldern G; Shou H; Baynes M; Marasigan RER; Calabresi PA; Zackowski KM
    Mult Scler Relat Disord; 2019 Jul; 32():107-113. PubMed ID: 31085489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Synthesis of Timed 25-Foot Walk Performance in Multiple Sclerosis.
    Sikes EM; Cederberg KL; Sandroff BM; Bartolucci A; Motl RW
    Arch Phys Med Rehabil; 2020 Mar; 101(3):524-534. PubMed ID: 31669296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor unit discharge characteristics and walking performance of individuals with multiple sclerosis.
    Almuklass AM; Davis L; Hamilton LD; Vieira TM; Botter A; Enoka RM
    J Neurophysiol; 2018 Apr; 119(4):1273-1282. PubMed ID: 29357453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatiotemporal gait changes in people with multiple sclerosis with different disease progression subtypes.
    Sato SD; Hiroi Y; Zoppo D; Buonaccorsi J; Miehm JD; van Emmerik REA
    Clin Biomech (Bristol, Avon); 2022 Dec; 100():105818. PubMed ID: 36435079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative sensory and motor measures detect change overtime and correlate with walking speed in individuals with multiple sclerosis.
    Zackowski KM; Wang JI; McGready J; Calabresi PA; Newsome SD
    Mult Scler Relat Disord; 2015 Jan; 4(1):67-74. PubMed ID: 25692092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
    Pavsic K; Pelicon K; Ledinek AH; Sega S
    Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.